VWA2
Basic information
Region (hg38): 10:114239254-114294489
Links
Phenotypes
GenCC
Source:
- congenital anomaly of kidney and urinary tract (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VWA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | 24 | ||||
missense | 10 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 0 | |||||
Total | 0 | 0 | 7 | 27 | 17 |
Variants in VWA2
This is a list of pathogenic ClinVar variants found in the VWA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-114248705-T-A | VWA2-related disorder | Benign (Sep 17, 2019) | ||
10-114248760-C-T | VWA2-related disorder | Uncertain significance (Sep 25, 2023) | ||
10-114253700-C-T | Benign (Oct 24, 2018) | |||
10-114254993-G-T | VWA2-related disorder | Likely benign (Nov 17, 2020) | ||
10-114255010-A-T | Benign (Dec 31, 2019) | |||
10-114261198-G-A | VWA2-related disorder | Likely benign (May 22, 2023) | ||
10-114261236-C-T | VWA2-related disorder | Likely benign (Feb 12, 2020) | ||
10-114261281-G-A | VWA2-related disorder | Likely benign (Jun 18, 2019) | ||
10-114272786-A-C | VWA2-related disorder | Likely benign (Dec 11, 2023) | ||
10-114277941-C-T | VWA2-related disorder | Benign (Jul 18, 2018) | ||
10-114277995-C-T | VWA2-related disorder | Likely benign (Feb 22, 2019) | ||
10-114278022-G-A | VWA2-related disorder | Benign (Oct 10, 2018) | ||
10-114278053-A-C | VWA2-related disorder | Benign (Dec 31, 2019) | ||
10-114278756-G-A | VWA2-related disorder | Benign (Oct 13, 2022) | ||
10-114278759-G-A | Benign (Oct 24, 2018) | |||
10-114278774-G-A | VWA2-related disorder | Likely benign (Oct 11, 2021) | ||
10-114278812-G-A | VWA2-related disorder | Uncertain significance (Apr 05, 2024) | ||
10-114284921-C-T | VWA2-related disorder | Likely benign (Feb 10, 2020) | ||
10-114284932-G-A | VWA2-related disorder | Uncertain significance (Jul 28, 2023) | ||
10-114284966-C-T | Benign (Dec 20, 2018) | |||
10-114285935-G-A | VWA2-related disorder | Likely benign (Jun 08, 2018) | ||
10-114285997-G-A | Benign (Dec 20, 2018) | |||
10-114286012-C-T | VWA2-related disorder | Likely benign (May 06, 2024) | ||
10-114286036-C-T | Benign (May 02, 2018) | |||
10-114286037-G-A | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VWA2 | protein_coding | protein_coding | ENST00000603594 | 11 | 52255 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.22e-17 | 0.00540 | 125403 | 2 | 343 | 125748 | 0.00137 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0123 | 457 | 456 | 1.00 | 0.0000288 | 4642 |
Missense in Polyphen | 131 | 127.95 | 1.0238 | 1568 | ||
Synonymous | -0.0506 | 201 | 200 | 1.00 | 0.0000132 | 1580 |
Loss of Function | 0.00627 | 26 | 26.0 | 0.999 | 0.00000127 | 304 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00441 | 0.00441 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00382 | 0.00365 |
Finnish | 0.000141 | 0.000139 |
European (Non-Finnish) | 0.000572 | 0.000563 |
Middle Eastern | 0.00382 | 0.00365 |
South Asian | 0.00198 | 0.00193 |
Other | 0.00119 | 0.00114 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.258
- rvis_EVS
- 0.12
- rvis_percentile_EVS
- 62.24
Haploinsufficiency Scores
- pHI
- 0.0699
- hipred
- N
- hipred_score
- 0.238
- ghis
- 0.385
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.150
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vwa2
- Phenotype
Gene ontology
- Biological process
- growth plate cartilage chondrocyte morphogenesis;calcium-independent cell-matrix adhesion;regulation of insulin receptor signaling pathway;protein homooligomerization
- Cellular component
- basement membrane;extracellular space;extracellular matrix;extracellular exosome
- Molecular function
- calcium ion binding;protein binding;identical protein binding